Avesta Biotherapeutics And Research Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
as on 08-07-2024
- Paid Up Capital ₹ 8.00 M
as on 08-07-2024
- Company Age 19 Year, 4 Months
- Last Filing with ROC 31 Mar 2017
- Revenue %
(FY 2017)
- Ebitda
- Net Worth -1.36%
(FY 2017)
- Total Assets %
(FY 2017)
About Avesta Biotherapeutics And Research
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2017. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 8.00 M, as per Ministry of Corporate Affairs (MCA) records.
Villoo Patell and Koenraad Wentink serve as directors at the Company.
- CIN/LLPIN
U24231KA2005PTC037008
- Company No.
037008
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Aug 2005
- Date of AGM
29 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Avesta Biotherapeutics And Research?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Villoo Patell  | Director | 31-Mar-2006 | Current |
Koenraad Wentink  | Director | 01-Oct-2008 | Current |
Financial Performance and Corporate Structure Insights of Avesta Biotherapeutics And Research.
Avesta Biotherapeutics And Research Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 1.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Avesta Biotherapeutics And Research?
In 2017, Avesta Biotherapeutics And Research had a promoter holding of 50.10% and a public holding of 49.90%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Avesta Biotherapeutics And Research?
Unlock and access historical data on people associated with Avesta Biotherapeutics And Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avesta Biotherapeutics And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avesta Biotherapeutics And Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
